|
Volumn 6, Issue 3, 2003, Pages 159-164
|
EurΩconference Angiogenesis II
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
CORTICOTROPIN;
CYCLOOXYGENASE 2 INHIBITOR;
GROWTH FACTOR;
TUMOR NECROSIS FACTOR ALPHA;
VANDETANIB;
VASCULOTROPIN;
VASCULOTROPIN C;
VASCULOTROPIN RECEPTOR 1;
VASCULOTROPIN RECEPTOR 2;
VATALANIB;
ANGIOGENESIS;
APOPTOSIS;
CANCER PREVENTION;
CELL MIGRATION;
CELL PROLIFERATION;
CELL SURVIVAL;
CIRCULATION;
CONFERENCE PAPER;
DNA LIBRARY;
DOWN REGULATION;
ENDOTHELIUM CELL;
ENZYME INHIBITION;
GENE EXPRESSION;
HUMAN;
HYPOXIA;
MEDICAL RESEARCH;
MEDICAL TECHNOLOGY;
MELANOMA;
NEOVASCULARIZATION (PATHOLOGY);
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN PHOSPHORYLATION;
REDUCTION;
SIGNAL TRANSDUCTION;
STEM CELL;
SURFACE PROPERTY;
VASCULARIZATION;
WOUND HEALING;
ANGIOGENESIS INHIBITORS;
ENDOTHELIAL CELLS;
EUROPE;
GENE EXPRESSION PROFILING;
GROWTH SUBSTANCES;
HUMANS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
RESEARCH;
|
EID: 1942439871
PISSN: 09696970
EISSN: None
Source Type: Journal
DOI: 10.1023/B:AGEN.0000021513.95526.cb Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|